Literature DB >> 35305227

Silymarin inhibits the progression of Ehrlich solid tumor via targeting molecular pathways of cell death, proliferation, angiogenesis, and metastasis in female mice.

Maggie E Amer1, Maher A Amer2, Azza I Othman2, Doaa A Elsayed2, Mohamed Amr El-Missiry3, Omar A Ammar4.   

Abstract

BACKGROUND: Plant-derived phytochemicals have been reported to exert anticancer activity. This study investigated the antitumor role of silymarin (Silybum marianum) (SMN) and its molecular targets in Ehrlich solid tumor xenografts in vivo. METHODS AND
RESULTS: Female Swiss albino mice were divided into three groups (of five animals each) that were engrafted with Ehrlich tumor (ET) cells with or without SMN treatment. The 3rd groups treated with DMSO only vehicle control group. A significant reduction in animal body mass and tumor volume/weight were observed in xenografted mice treated with SMN. SMN modulated oxidative stress in tumors while enhancing the antioxidant levels in mouse serum. SMN activated both mitochondrial and death receptor-related apoptosis pathways and induced cell cycle arrest, marked by a significant downregulation of cyclin D1 in SMN-treated tumors. Significant decreases in RNA content and protein expression levels of Ki-67 and proliferating cell nuclear antigen were observed in ET cells. Additionally, SMN downregulated vascular endothelial growth factor and nuclear factor-kappa B levels indicating anti-angiogenesis activity of this agent. SMN upregulated the expression of E-cadherin in tumor tissue suggesting, that SMN has potential ability to inhibit metastasis. Tumor tissue from SMN-treated animals showed a remarkable degeneration and reduction in the neoplastic cell density.
CONCLUSIONS: The anticancer effect was associated with apparent apoptosis in neoplastic cells with abundance of multifocal necrotic areas. SMN was found to inhibit ET growth via enhancing apoptosis, inhibition of cell division and reduction in angiogenesis in vivo. Hypothetical scheme of SMN antitumor effects (mechanism of signaling) in solid ET in vivo. SMN anticancer effect may be mediated by molecular mediators that affect proliferation, cell cycle activity, apoptotic pathways, angiogenesis, and metastasis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Apoptosis; Cell cycle arrest; E-cadherin; Nuclear factor-kappa B; Oxidative stress; Solid Ehrlich carcinoma

Mesh:

Substances:

Year:  2022        PMID: 35305227     DOI: 10.1007/s11033-022-07315-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  46 in total

1.  Ameliorative effects of 9-diaminoacridine derivative against Ehrlich ascites carcinoma-induced hepatorenal injury in mice.

Authors:  Mabrouk Attia Abd Eldaim; Ehab Tousson; Ibrahim El Tantawy El Sayed; Asmaa Zakaria Abd Elmaksoud; Abdullah A S Ahmed
Journal:  Environ Sci Pollut Res Int       Date:  2021-01-07       Impact factor: 4.223

2.  Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells.

Authors:  M A El-Missiry; A F Abd El-Aziz
Journal:  Cancer Lett       Date:  2000-04-14       Impact factor: 8.679

3.  Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma.

Authors:  Reem M Hazem; Anhar A Mohamed; Nagat Ghareb; Eman T Mehanna; Noha M Mesbah; Dina M Abo-Elmatty; Mohamed Saleh Elgawish
Journal:  Eur J Pharmacol       Date:  2020-11-21       Impact factor: 4.432

4.  What are the immune responses during the growth of Ehrlich's tumor in ascitic and solid form?

Authors:  Ivan Brito Feitosa; Bruno Mori; Carolina Bioni Garcia Teles; Alysson Guimarães da Costa
Journal:  Life Sci       Date:  2020-10-13       Impact factor: 5.037

Review 5.  Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator.

Authors:  Zohreh Jahanafrooz; Nasrin Motamed; Beate Rinner; Ahad Mokhtarzadeh; Behzad Baradaran
Journal:  Life Sci       Date:  2018-10-09       Impact factor: 5.037

6.  Grape seed extract ameliorated Ehrlich solid tumor-induced hepatic tissue and DNA damage with reduction of PCNA and P53 protein expression in mice.

Authors:  Mabrouk Attia Abd Eldaim; Ehab Tousson; Mohamed Mohamed Soliman; Ibrahim El Tantawy El Sayed; Abdel Aleem H Abdel Aleem; Hebatalla Nashaat Elsharkawy
Journal:  Environ Sci Pollut Res Int       Date:  2021-04-13       Impact factor: 4.223

7.  Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells.

Authors:  Sung-Hyun Kim; Gang-Sik Choo; Eun-Seon Yoo; Joong-Seok Woo; So-Hee Han; Jae-Han Lee; Ji-Youn Jung
Journal:  Oncol Rep       Date:  2019-08-28       Impact factor: 3.906

8.  A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation.

Authors:  Nariman K Badr El-Din; Sameh M Shabana; Bashar A Abdulmajeed; Mamdooh Ghoneum
Journal:  BMC Complement Med Ther       Date:  2020-04-28

9.  Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy.

Authors:  Sneha Mishra; Ankit Kumar Tamta; Mohsen Sarikhani; Perumal Arumugam Desingu; Shruti M Kizkekra; Anwit Shriniwas Pandit; Shweta Kumar; Danish Khan; Sathees C Raghavan; Nagalingam R Sundaresan
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.